{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:32:19Z","timestamp":1769596339894,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Histone deacetylase 4 (HDAC4) regulates the progression of autoimmune diseases. This study aimed to further investigate the correlation between HDAC4 and Th cells, inflammation, disease activity, and treatment response in patients with ankylosing spondylitis (AS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 132 active patients with AS were enrolled, of whom 54 patients received TNF inhibitor (TNFi) and 78 patients received NSAID. Serum HDAC4 was measured by ELISA in patients with AS before treatment (W0) and at week (W)4, W8, and W12 after treatment. Meanwhile, serum HDAC4 was detected in 30 patients with osteoarthritis and in 30 healthy controls (HCs) by ELISA. Besides, na\u00efve CD4<jats:sup>+<\/jats:sup> T cells from patients with AS were isolated, followed by modulation of HDAC4 and then polarization toward Th1, Th2, and Th17.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Histone deacetylase 4 was reduced in patients with AS compared with HCs and patients with osteoarthritis (both <jats:italic>P<\/jats:italic> &amp;lt; 0.01). In patients with AS, HDAC4 was negatively correlated with TNF (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), IL-1\u03b2 (<jats:italic>P<\/jats:italic> = 0.003), Th17 proportion (<jats:italic>P<\/jats:italic> = 0.008), C-reactive protein (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), and ASDAS (<jats:italic>P<\/jats:italic> = 0.038), but not with IL-6, Th1 proportion, or other characteristics. Meanwhile, HDAC4 increased from W0 to W12 (<jats:italic>P<\/jats:italic> &amp;lt; 0.001); HDAC4 at W8 (<jats:italic>P<\/jats:italic> = 0.014) and W12 (<jats:italic>P<\/jats:italic> = 0.006) was raised in ASAS40-response patients than ASAS40-non-response patients; further subgroup analysis showed that HDAC4 at W12 was higher in ASAS40-response patients than ASAS40-non-response patients (<jats:italic>P<\/jats:italic> = 0.016) in the TNFi-treated group, but not in the NSAID-treated group. In addition, HDAC4 negatively regulated the polarization of na\u00efve CD4<jats:sup>+<\/jats:sup> T cells toward Th17 (<jats:italic>P<\/jats:italic> &amp;lt; 0.01), but not Th1 or Th2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Histone deacetylase 4 is associated with lower inflammation, and the disease activity negatively regulates Th17 polarization, whose increment after treatment reflects favorable outcomes in patients with AS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.875341","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T14:00:24Z","timestamp":1651845624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Blood HDAC4 Variation Links With Disease Activity and Response to Tumor Necrosis Factor Inhibitor and Regulates CD4+ T Cell Differentiation in Ankylosing Spondylitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Bin","family":"Dou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-020-04537-0","article-title":"Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis","volume":"40","author":"Zhao","year":"2020","journal-title":"Rheumatol Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1038\/s41598-018-25933-4","article-title":"Trends in the prevalence and incidence of ankylosing spondylitis in South Korea, 2010-2015 and estimated differences according to income status","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jval.2020.04.1837","article-title":"Effects of intravenous golimumab on health-related quality of life in patients with ankylosing spondylitis: 28-week results of the GO-ALIVE trial","volume":"23","author":"Reveille","year":"2020","journal-title":"Value Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40259-020-00408-z","article-title":"Comparison of the efficacy and safety of Adalimumab (Humira) and the Adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis: a multicenter, randomized, double-blind, parallel, phase III clinical trial","volume":"34","author":"Su","year":"2020","journal-title":"BioDrugs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10787-017-0386-4","article-title":"The effects of beta-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte\/macrophage, J774 cell line","volume":"26","author":"Jafarnezhad-Ansariha","year":"2018","journal-title":"Inflammopharmacology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18502\/jovr.v16i3.9440","article-title":"Ankylosing spondylitis","volume":"16","author":"Ebrahimiadib","year":"2021","journal-title":"J Ophthalmic Vis Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/jcb.29365","article-title":"The posttranslational modification of HDAC4 in cell biology: mechanisms and potential targets","volume":"121","author":"Hou","year":"2020","journal-title":"J Cell Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2021.07.049","article-title":"Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance","volume":"520","author":"Ma","year":"2021","journal-title":"Cancer Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainresbull.2020.06.010","article-title":"Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the neuroprotective effects of alpha-phenyl tropolone, HPOB, and sodium valproate","volume":"162","author":"Demyanenko","year":"2020","journal-title":"Brain Res Bull."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.2147\/JIR.S336099","article-title":"Mesenchymal stem cell-originated exosomal circular RNA circFBXW7 attenuates cell proliferation, migration and inflammation of fibroblast-like synoviocytes by targeting miR-216a-3p\/HDAC4 in rheumatoid arthritis","volume":"14","author":"Chang","year":"2021","journal-title":"J Inflamm Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10753-021-01538-4","article-title":"Circular RNA circ_0008360 inhibits the proliferation, migration, and inflammation and promotes apoptosis of fibroblast-like synoviocytes by regulating miR-135b-5p\/HDAC4 axis in rheumatoid arthritis","volume":"45","author":"Hao","year":"2022","journal-title":"Inflammation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12967-021-02812-7","article-title":"HDAC4 induces the development of asthma by increasing slug-upregulated CXCL12 expression through KLF5 deacetylation","volume":"19","author":"Wei","year":"2021","journal-title":"J Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12872-021-01980-0","article-title":"MicroRNA-200b-3p promotes endothelial cell apoptosis by targeting HDAC4 in atherosclerosis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.prp.2018.04.009","article-title":"Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease","volume":"214","author":"Pei","year":"2018","journal-title":"Pathol Res Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ni.3292","article-title":"The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema","volume":"16","author":"Lu","year":"2015","journal-title":"Nat Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cells10020280","article-title":"Modulatory impact of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on T helper cell differentiation","volume":"10","author":"Kuca-Warnawin","year":"2021","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3389\/fimmu.2020.02151","article-title":"Semaphorin 4D induces an imbalance of Th17\/Treg cells by activating the Aryl hydrocarbon receptor in ankylosing spondylitis","volume":"11","author":"Xie","year":"2020","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018","article-title":"The assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1136\/annrheumdis-2018-213511","article-title":"Maresin 1 improves the Treg\/Th17 imbalance in rheumatoid arthritis through miR-21","volume":"77","author":"Jin","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.21037\/tlcr-21-982","article-title":"Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer","volume":"10","author":"Shao","year":"2021","journal-title":"Transl Lung Cancer Res."},{"key":"B24","first-page":"189","article-title":"Expression of HDAC4 in stage B hepatocellular carcinoma and its influence on survival","volume":"49","author":"Wang","year":"2019","journal-title":"Ann Clin Lab Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.18632\/aging.100980","article-title":"Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma","volume":"8","author":"Zeng","year":"2016","journal-title":"Aging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.7150\/jca.26780","article-title":"Prognosis analysis of histone deacetylases mRNA expression in ovarian cancer patients","volume":"9","author":"Zhou","year":"2018","journal-title":"J Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13148-016-0218-1","article-title":"DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease","volume":"8","author":"Zeybel","year":"2016","journal-title":"Clin Epigenetics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"737599","DOI":"10.3389\/fcell.2021.737599","article-title":"Hsa_circ_0000652 aggravates inflammation by activation of macrophages and enhancement of OX40\/OX40L interaction in ankylosing spondylitis","volume":"9","author":"Song","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms222413325","article-title":"B cell involvement in the pathogenesis of ankylosing spondylitis","volume":"22","author":"Wilbrink","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12125","DOI":"10.7717\/peerj.12125","article-title":"Identification of immune related cells and crucial genes in the peripheral blood of ankylosing spondylitis by integrated bioinformatics analysis","volume":"9","author":"Zheng","year":"2021","journal-title":"PeerJ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.5758","article-title":"The loss of histone deacetylase 4 in macrophages exacerbates hepatic and adipose tissue inflammation in male but not in female mice with diet-induced non-alcoholic steatohepatitis","volume":"255","author":"Kang","year":"2021","journal-title":"J Pathol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roab039","article-title":"JKAP serves as a potential biomarker for the evaluation of inflammatory condition, disease activity, and treatment response to TNF inhibitor in ankylosing spondylitis patients","author":"Zhou","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s10787-021-00854-3","article-title":"Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis","volume":"29","author":"Li","year":"2021","journal-title":"Inflammopharmacology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.berh.2018.07.010","article-title":"Th17 cell responses in spondyloarthritis","volume":"31","author":"Gaston","year":"2017","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"696973","DOI":"10.3389\/fimmu.2021.696973","article-title":"Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: a meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1017938","DOI":"10.1155\/2021\/1017938","article-title":"Immunological changes in peripheral blood of ankylosing spondylitis patients during anti-TNF-alpha therapy and their correlations with treatment outcomes","volume":"2021","author":"Chen","year":"2021","journal-title":"J Immunol Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-021-00601-1","article-title":"Histone deacetylase HDAC4 participates in the pathological process of myocardial ischemia-reperfusion injury via MEKK1\/JNK pathway by binding to miR-206","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6693542","DOI":"10.1155\/2021\/6693542","article-title":"Cytokines that modulate the differentiation of Th17 cells in autoimmune uveitis","volume":"2021","author":"Guo","year":"2021","journal-title":"J Immunol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00124743-200212000-00005","article-title":"Prescription and tolerability of meloxicam in day-to-day practice: postmarketing observational cohort study of 13,307 patients in Germany","volume":"8","author":"Zeidler","year":"2002","journal-title":"J Clin Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"160326","DOI":"10.1155\/2011\/160326","article-title":"Cost-effectiveness evaluation of etoricoxib versus celecoxib and nonselective NSAIDs in the treatment of ankylosing spondylitis in Norway","volume":"2011","author":"Jansen","year":"2011","journal-title":"Int J Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.875341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T14:00:28Z","timestamp":1651845628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.875341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":40,"alternative-id":["10.3389\/fmed.2022.875341"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.875341","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"875341"}}